Trade Gilead ^GILD

Gilead Sciences, Inc. $GILD Shares Bought by Mn Services Vermogensbeheer B.V.

Gilead Expands Autoimmune Ambitions With Ouro Deal And Galapagos Collaboration

Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

6,329 Shares in Gilead Sciences, Inc. $GILD Acquired by WESPAC Advisors LLC

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Gilead Sciences, Inc. $GILD Stake Lifted by USA Financial Formulas

5,845 Shares in Gilead Sciences, Inc. $GILD Bought by Parsons Capital Management Inc. RI - Stock Observer

Synergy Asset Management LLC Has $204,000 Holdings in Gilead Sciences, Inc. $GILD

Exchange Traded Concepts LLC Raises Position in Gilead Sciences, Inc. $GILD

Wedge Capital Management L L P NC Sells 10,133 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

CAR T-Cell Therapy Market to Hit USD 13.78 Billion by 2031, Driven by Rising Global Cancer Prevalence - Insights by Product, Target, Indication, Demographic, Region, and Competitive Landscape

Gilead Sciences FY2026 EPS Increased by Erste Group Bank

NatWest Group plc Has $5.40 Million Stock Holdings in Gilead Sciences, Inc. $GILD

FY2026 EPS Forecast for Gilead Sciences Lifted by Analyst - Stock Observer

Gilead Sciences, Inc. $GILD Shares Purchased by Global X Japan Co. Ltd. - Daily Political

A Look At Gilead Sciences (GILD) Valuation After Recent Share Price Weakness

Gilead to Acquire Ouro Medicines in $2.18B Deal, Expand Inflammation Pipeline

Metastatic Triple-Negative Breast Cancer Market: Strong Growth Potential Across APAC Through 2036, Driven by Innovation and Rising Disease Burden | DelveInsight

Czech National Bank Buys 12,009 Shares of Gilead Sciences, Inc. $GILD

17,800 Shares in Gilead Sciences, Inc. $GILD Acquired by Pensionfund Sabic - Markets Daily

Pensionfund Sabic Takes $2.19 Million Position in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Eyes $2.2 Billion Autoimmune Push With Ouro Deal

Gilead Expands Into Autoimmune With Ouro Deal And Galapagos Alliance

Rights to antibody drug by China's Keymed change hands in Gilead acquisition of Ouro | South China Morning Post

Gilead pens dual-purpose $2B Ouro M&A deal with Galapagos | BioWorld

Gilead Sciences Acquires Ouro Medicines for Over $2 Billion to Expand Immunology Pipeline, ETPharma

Dow Jones Top Company Headlines at 9 PM ET: Estee Lauder in Talks to Acquire Spain's Puig to Create Global Beauty Giant | Gilead ... | Morningstar

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets - Update | Morningstar

Gilead to buy Ouro Medicines for up to $2.2 billion

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion | Morningstar

Gilead to buy biotech firm Ouro Medicines in over $2 billion deal

Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

Galapagos en Gilead in vergevorderde gesprekken over samenwerking om een first-in-class T-cel-engagerprogramma voor auto-immuunziekten verder te ontwikkelen

-- Acquisition Adds Clinical Stage Bispecific BCMAxCD3 T Cel

Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases

Demand surges in Nigeria for new HIV prevention injection ahead of rollout | Africanews

Wealth Enhancement Advisory Services LLC Has $77.22 Million Stock Holdings in Gilead Sciences, Inc. $GILD

Nordea Investment Management AB Has $630.06 Million Stake in Gilead Sciences, Inc. $GILD

Henrickson Nauta Wealth Advisors Inc. Purchases 7,074 Shares of Gilead Sciences, Inc. $GILD - Markets Daily

Nordea Investment Management AB Increases Position in Gilead Sciences, Inc. $GILD - Stock Observer

IAM Advisory LLC Takes $1.27 Million Position in Gilead Sciences, Inc. $GILD

BCGM Wealth Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD

Union Bancaire Privee UBP SA Grows Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Therapeutics Stocks Q4 Teardown: Moderna (NASDAQ:MRNA) Vs The Rest

Groupama Asset Managment Grows Stock Holdings in Gilead Sciences, Inc. $GILD

Anderson Hoagland & Co. Purchases New Stake in Gilead Sciences, Inc. $GILD

AIA Group Ltd Increases Stock Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Wilmington Savings Fund Society FSB - Daily Political

GILD: HIV Franchise And Oncology Expansion Will Shape Bullish Long Term Outlook

Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care

Gilead Sciences, Inc. $GILD Shares Bought by Swiss Life Asset Management Ltd

Johanna Mercier Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - Markets Daily

Swiss Life Asset Management Ltd Purchases 31,807 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Sunbelt Securities Inc. Trims Holdings in Gilead Sciences, Inc. $GILD - Daily Political

A Look At Gilead Sciences (GILD) Valuation As Recent Returns Send Mixed Signals

Danske Bank A S Takes $133.05 Million Position in Gilead Sciences, Inc. $GILD

Captrust Financial Advisors Has $211.80 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Gilead Sciences, Inc. $GILD Shares Purchased by Achmea Investment Management B.V.

Gilead Sciences, Inc. $GILD Holdings Cut by WBI Investments LLC - Daily Political

Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares

Gilead Sciences (NASDAQ:GILD) CFO Sells $432,690.00 in Stock

Fort Point Capital Partners LLC Sells 8,153 Shares of Gilead Sciences, Inc. $GILD

CSM Advisors LLC Sells 42,400 Shares of Gilead Sciences, Inc. $GILD

Bank of Nova Scotia Sells 319,843 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences Conference: 6-Month HIV Regimens, 12-Month PrEP, Livdelzi Expansion, Oncology Push - Stock Observer

Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and "long cycle" growth - Daily Political

2 Mega-Cap Nasdaq Stocks with Unusual Options Activity: What to Watch

Gilead Sciences, Inc. (NASDAQ:GILD) Short Interest Down 15.7% in February

Gilead Sciences, Inc. $GILD Shares Sold by Holocene Advisors LP - Daily Political

Crawford Investment Counsel Inc. Decreases Stock Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades

Calydon Capital Has $7.34 Million Position in Gilead Sciences, Inc. $GILD

BNP Paribas Has $7.71 Million Stake in Gilead Sciences, Inc. $GILD

Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Rating of "Moderate Buy" from Brokerages - Markets Daily

Ameriprise Financial Inc. Buys 400,002 Shares of Gilead Sciences, Inc. $GILD

Alliancebernstein L.P. Sells 258,213 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences (NASDAQ:GILD) Upgraded by Wall Street Zen to Strong-Buy Rating

BNP Paribas Sells 16,020 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Goldman Sachs Healthcare Stocks: Top 10 Stock Picks

Top Pharmaceutical Stocks To Watch Today - March 14th - Stock Observer

Dodge & Cox Trims Stock Position in Gilead Sciences, Inc. $GILD

Gilead Sciences (NASDAQ:GILD) Upgraded at Wall Street Zen

Harvest Fund Management Co. Ltd Has $10.34 Million Position in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences, Inc. $GILD Shares Sold by Prudential PLC - Daily Political

Dodge & Cox Reduces Stock Position in Gilead Sciences, Inc. $GILD - Daily Political